Evidence map›Paper›PMID 35129299›Full record

Observational studyJournal of the International AIDS Society2022

Incremental costs of integrated PrEP provision and effective use counselling in community-based platforms for adolescent girls and young women in South Africa: an observational study.

Edinah Mudimu, Jack Sardinia, Sahar Momin, Andrew Medina-Marino, Charl Bezuidenhout, Linda-Gail Bekker, Ruanne V Barnabas, Kathryn Peebles

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the International AIDS Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Edinah MudimuDepartment of Decision Sciences, College of Economic and Management Sciences, University of South Africa, Pretoria, South Africa.ORCID 0000-0002-5479-9255
Jack SardiniaDepartment of Health Policy and Management, School of Public Health, Columbia University, Columbia, Mailman, USA.
Sahar MominDepartment of Health Policy and Management, School of Public Health, Columbia University, Columbia, Mailman, USA.
Andrew Medina-MarinoResearch Unit, Foundation for Professional Development, East London, South Africa.ORCID 0000-0002-0095-4141
Charl BezuidenhoutResearch Unit, Foundation for Professional Development, East London, South Africa.
Linda-Gail BekkerDesmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-0755-4386
Ruanne V BarnabasDepartment of Global Health, School of Public Health and Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-1793-6003
Kathryn PeeblesDepartment of Global Health, School of Public Health and Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-2095-7446
Desmond Tutu HIV Foundation · ZAUniversity of Washington · USZero to Three · USFoundation for Professional Development · ZAUniversity of South Africa · ZA

Funding

The Community PrEP StudyR01MH114648 · NIMH · FOUNDATION FOR PROFESSIONAL DEVELOPMENT · PI BEKKER, LINDA-GAIL GAIL, MEDINA-MARINO, ANDREW · 2017 to 2021
$2.4M
NIMH NIH HHS R01 MH114648NIMH NIH HHS R01MH114648
6 · The paper itself

Abstract

introductionAdolescent girls and young women (AGYW) are a priority population for pre-exposure prophylaxis (PrEP), a highly effective HIV prevention method. However, effective PrEP use among AGYW has been low. Interventions to support PrEP effective use may improve pill-taking. Affordability of PrEP programs depends on their cost. We, therefore, evaluated the cost of community-based PrEP with effective use counselling.

methodsCost data from a randomized controlled trial were used to evaluate the cost of PrEP provision with effective use counselling offered to AGYW through community-based HIV testing platforms between November 2018 and November 2019. AGYW were randomized to receive (1) group-based community health club effective use counselling, (2) individualized effective use counselling or (3) community-based PrEP dispensary. Task shifting of effective use counselling from nurses to trained lay counsellors was implemented in groups 1 and 2. Personnel costs were estimated from time-and-motion observations and staff interviews. Expenditure and ingredients-based approaches were used to estimate costs for medical and non-medical supplies.

resultsIn total, 603 AGYW initiated PrEP and accrued a total of 1280 months on PrEP. Average cost per person-month on PrEP with group-based community health club, individualized effective use counselling and community-based PrEP dispensary under the Department of Health scenario were similar and high (USD $55.32, $55.65 and $55.46, respectively) due to low PrEP client volume observed in the clinical trial. Increasing client volume (scaled Department of Health scenario) reduced cost per-person month estimates to USD $15.48, $26.40 and $13.99, respectively.

conclusionsAs designed, individualized effective use counselling increased the cost of standard-of-care PrEP delivery by 89%, group-based community health effective use counselling increased the cost of standard-of-care PrEP delivery by 11%. These estimates can inform cost-effectiveness and budget impact analysis for PrEP provision with effective use counselling services.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdolescentCounselingFemaleHumansRandomized Controlled Trials as TopicSouth AfricaAnti-HIV AgentsadherenceCBCT platformsdifferentiated careHIV preventionmicro-costingPrEP effective use

Identifiers

PMID35129299
PMCPMC8819637
OpenAlexW4210385936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.